This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
“We’re the richest country in the world. It’s callous to say it’s costing too mu...
Health insurers are using more AI but a lack of transparency makes it difficult ...
Monarez is the CDC's acting director and a longtime biosecurity expert with ties...
The genetics company's bankruptcy is bad for co-founder Anne Wojcicki and shareh...
Prominent outside scientists who help the NIH evaluate its internal research pro...
Monarez is the CDC's acting director and a longtime biosecurity expert with ties...
This week in healthcare business news: Changes are coming to Medicare Advantage,...
Today in "The Readout" newsletter: Alnylam's Amvuttra enters ATTR-CM drug race, ...
Can philanthropy rescue struggling small biotechs? Authors of a new essay believ...
23andMe plans to file for bankruptcy and CEO and co-founder Anne Wojcicki will d...
In today's Morning Rounds newsletter, proposed cuts to cancer research under the...
23andMe said late Sunday it will file for bankruptcy and CEO and co-founder Anne...
23andMe said late Sunday it will file for bankruptcy and CEO and co-founder Anne...
A generation of scientists and their future work will be lost if the U.S. doesn’...
The bill targets fentanyl-related substances, but illegally manufactured fentany...
Small biotech companies are the heart of drug innovation, but they need help. Ph...
Cancer research has had bipartisan support. But Trump administration budget cuts...
Trump's former FDA commissioner criticized the current administration's approach...
Wavering on vaccines and slashing public health spending could allow the Texas o...
Today in "The Readout" newsletter: Alnylam's Amvuttra enters ATTR-CM drug race, ...
The NYU Global Public Health team was the in-person-event winner of STAT Madness...
Bill Nye the Science Guy rebukes RFK Jr., WHO calls for help on TB outbreak, and...
J&J plans to spend over $55 billion to build four plants in the U.S. as the Trum...
“With measles resurging, we cannot rely on guidelines designed for an era when t...